VMP 42034011000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Cinnarizine 15mg tablets
BNF code 0406000D0AAAAAA
Virtual Therapeutic Moiety Cinnarizine
Date identifier became valid 7 Jul 2023
Previous product identifier 322061003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Cinnarizine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cinnarizine 15mg tablets (A A H Pharmaceuticals Ltd)
Cinnarizine 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Cinnarizine 15mg tablets (Almus Pharmaceuticals Ltd)
Cinnarizine 15mg tablets (Medihealth (Northern) Ltd)
Cinnarizine 15mg tablets (Novumgen Ltd)
Cinnarizine 15mg tablets (Phoenix Healthcare Distribution Ltd)
Cinnarizine 15mg tablets (Sigma Pharmaceuticals Plc)
Cinnarizine 15mg tablets (Teva UK Ltd)
Cinnarizine 15mg tablets (Viatris UK Healthcare Ltd)
Stugeron 15mg tablets (Johnson & Johnson Ltd)
Virtual Medicinal Product Packs
Cinnarizine 15mg tablets 100 tablet
Cinnarizine 15mg tablets 15 tablet
Cinnarizine 15mg tablets 28 tablet
Cinnarizine 15mg tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.

Feedback